Premium
Adherence to risperidone long‐acting injection dosing recommendations
Author(s) -
Mangan Brian,
Rogers Clive,
Wilton Kristina
Publication year - 2009
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.139
Subject(s) - risperidone , dosing , audit , cohort , psychiatry , medicine , mental health , psychology , schizophrenia (object oriented programming) , pharmacology , accounting , business
The pharmacokinetic profile of risperidone long‐acting injection (RLAI) has lead to specific recommendations for its treatment initiation. A team of Mental Health Nurse Advisers conducted this audit in a cohort of 1647 patients from 32 centres in the UK to assess to what extent treatment with RLAI is initiated according to these recommendations and how this affects treatment adherence. Copyright © 2009 Wiley Interface Ltd